Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargeting

Clinical Cancer Research

Volumn 5, Issue 10 SUPPL., 1999, Pages

  Sandström, Per ^a   Johansson, Amanda ^a   Ullén, Anders ^a   Rathsman, Sandra ^a   Riklund Åhlström, Katrine ^a   Stigbrand, Torgny ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; ISOTOPE LABELING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOISOTOPE DISTRIBUTION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; IMMUNOCHEMISTRY; IMMUNOGLOBULIN IDIOTYPES; MICE; MICE, NUDE; PRECIPITIN TESTS; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY;

EID: 0032724042     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. 131I-labeled monoclonal antibodies administered to man. Int. J. Radiat. Appl. Instrum. Part B, 16: 153-158, 1989.
2. 2 in nude mice bearing human tumor xenografts. Cancer (Phila.), 73(Suppl.): 816-823, 1994.
3. Yokota, T., Milenic, D. E., Whitlow, M., and Schlom, J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52: 3402-3408, 1992.
4. Hu, S., Shively, L., Raubitschek, A., Sherman, M., Williams, L. E., Wong, J. Y., Shively, J. E., and Wu, A. M. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res., 56: 3055-3061, 1996.
5. Begent, R. H., Verhaar, M. J., Chester, K. A., Casey, J. L., Green, A. J., Napier, M. P., Hope-Stone, L. D., Cushen, L., Keep, P. A., Johnson, C. J., Hawkins, R. E., Hilson, A. J. W., and Robson, L. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat. Med., 2: 979-984, 1996.
6. Pimm, M. V., Fells, H. F., Perkins, A. C., and Baldwin, R. W. Iodine-131 and indium-111 labelled avidin and streptavidin for pretargeting immunoscintigraphy with biotinylated anti-tumour monoclonal antibody. Nucl. Med. Commun., 9: 931-941, 1988.
7. Paganelli, G., Pervez, S., Siccardi, A. G., Rowlinson, G., Deleide, G., and Chiolerio, F. Intraperitoneal radiolocalization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer, 45: 1184-1189, 1990.
8. DeNardo, S. J., DeNardo, G. L., and Richman, C. M. Enhancement of clinical radioimmunotherapy for cancer and role of cytokines. J. Natl. Cancer Inst., 84: 374-375, 1992.
9. DeNardo, S. J., O'Grady, L. F., Warhoe, K. A., and DeNardo, G. L. Radioimmunotherapy in patients with metastatic breast cancer. J. Nucl. Med., 33: 862-863, 1992.
10. DeNardo, G. L., DeNardo, S. J., Maddock, S. W., Zeiter, P. C., Maddock, E. N., and Matthews, K. J. Efficacy of immunophoresis to reduce myelosuppression in radioimmunotherapy. J. Nucl. Med., 33: 863-864, 1992.
11. DeNardo, G. L., Maddock, S. W., Sgouros, G., Scheibe, P. O., and DeNardo, S. J. Immunoadsorption: an enhanced strategy for radioimmunotherapy. J. Nucl. Med., 34: 1255-1262, 1993.
12. Blumenthal, R. D., Sharkey, R. M., Forman, D., Wong, G., and Goldenberg, D. M. Cytokine intervention permits dose escalation of radio-antibody. An analysis of myelostimulation by bolus versus continuous infusion of IL-1/GM-CSF. Cancer (Phila.), 73(Suppl.): 1083-1092, 1994.
13. Strand, S-E., Norrgren, K., Ingvar, C., Erlandsson, K., and Persson, E. C. Plasmapheresis as a tool for enhancing contrast in radioimmuno-imaging and modifying absorbed doses in radioimmunotherapy. Med. Phys., 16: 465, 1989.
14. Maddock, S. W., Maddock, E. N., Quittner, S. F., Hamstra, A., and Pastusiak, H. Immunoadsorption of circulating monoclonal antibody. In: 7th International Congress of Immunology, p. 771. New York: 7, 1989.
15. Lear, J. L., Kasliwal, R. K., Feyerabend, A. J., Pratt, J. P., Bunn, P. A., Dienhart, D. G., Gonzalez, R., Johnson, T. K., Bloedow, D. C., and Maddock, S. W. Improved tumor imaging with radiolabelled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column. Radiology, 179: 509-512, 1991.
16. Johnson, T. K., Maddock, S. W., Kasliwal, R., Lear, J. L., Feyerabend, A. J., Dienhardt, D. G., Ceriani, R. L., and Bunn, P. A., Jr. Radioimmunoadsorption of KC-4G3 Ab in peripheral blood: implications for radioimmunotherapy. Antibody Immunoconjug. Radiopharm., 4: 885-893, 1991.
17. Barratt, G., Ryman, B., Begent, R., Keep, P. A., Searle, F., Boden, J. A., and Bagshawe, K. D. Improved radioimmunodetection of tumors using liposome-entrapped antibody. Biochim. Biophys. Acta, 762: 154-164, 1983.
18. Begent, R., Bagshawe, K., Pedley, R. B., Searle, F., Ledermann, J. A., Green, A. J., Keep, P. A., Chester, K. A., Glaser, M. G., and Dale, R. G. Use of second antibody in radioimmunotherapy. Natl. Cancer Inst. Monogr., 3: 59-61, 1987.
19. Pimm, M., and Baldwin, R. Syngeneic anti-idiotypic antibody prevents localization of a murine monoclonal antibody in human tumour xenografts. Eur. J. Cancer. 26: 567-568, 1990.
20. Pimm, M., and Gribben, S. Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumor localization of murine monoclonal antibodies and fragments. Anticancer Res., 13: 241-248, 1993.
21. Sharkey, R., Boerman, O., Natale, A., Pawly, K. D., Monestier, M., Losman, M. J., and Goldenberg, D. M. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype in tumor bearing nude mice. Int. J. Cancer, 51: 266-273, 1992.
22. Marshall, D., Pedley, R., Boden, J., Boden, R., and Begent, R. Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. Br. J. Cancer, 69: 502-507, 1994.
23. Ullén, A., Sandström, P., Riklund Åhlström, K., Sundström, B., Nilsson, B., Arlestig, L., and Stigbrand, T. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor/nontumor ratio in experimental radioimmunolocalization. Cancer Res., 55: 5868-5873, 1995.
24. Roux, K. H. Immunoelectron microscopy of idiotype-anti-idiotype complexes. Methods Enzymol., 178: 130-144, 1989.
25. Roux, K. H., and Tankersley, D. L. A view of the idiotypic repertoire: electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J. Immunol., 144: 1387-1395, 1990.
26. Phillips, M. L., Oi, V. T., and Schumaker, V. N. Electron microscopic study of ring-shaped, bivalent hapten, bivalent antidansyl monoclonal antibody complexes with identical variable domains but IgG1, IgG2a and IgG2b constant domains. Mol. Immunol., 27: 181-190, 1990).
27. Roux, K. H., and Greenspan, N. S. Monitoring the formation of soluble immune complexes composed of idiotype and anti-idiotype antibodies by electron microscopy. Mol. Immunol., 31: 599-606, 1994.
28. Roux, K. H., Strelets, L., and Michaelsen, T. E. Molecular flexibility of human IgG sub-classes. J. Immunol., 159: 3372-3382, 1997.
29. Roux, K. H., Strelets, L., Brekke, O. H., Sandlie, I., and Michaelsen, T. E. Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE and IgA2, to form small immune complexes: a role for flexibility and geometry. J. Immunol., 161: 4083-4090, 1998.
30. Stigbrand, T., Johansson, B., Riklund, K., Hietala, S-O., and Ekelund, L. Tumour radioimrnunolocalization in nude mice by use of untiplacental alkaline phosphatase monoclonal antibodies. Tumor Biol., 10: 243-251, 1989.
31. 131I-labeled monoclonal antibodies. Anticancer Res., 10: 379-384, 1990.
32. 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies. Anticancer Res., 11: 555-560, 1991.
33. 131I-labeled anti-PLAP monoclonal antibodies. Acta Radiol., 32: 375-380, 1991.
34. Sandström, P., Johansson, A., Ullén, A., Behravan, G., and Stigbrand, T. Differences in sequence and affinity between three monoclonal anti-idiotypic antibodies against one anti-placental alkaline phosphatase idiotypic antibody. Tumor Targeting, 3: 80-86, 1998.
35. Ullén, A., Nilsson, B., Riklund-Åhlström, K., Makiya, R., and Stigbrand, T. In vivo and in vitro interactions between idiotypic and anti-idiotypic monoclonal antibodies against placental alkaline phosphatase. J. Immunol. Methods. 183: 155-165, 1995.
36. Millan, J., and Stigbrand, T. Antigenic determinants of human placental and testicular alkaline phosphatases as mapped by monoclonal antibodies. Eur. J. Biochem., 136: 1-7, 1983.
37. Sundström, B. E., Nathrath, W. B. J., and Stigbrand, T. Diversity in immunoreactivity of tumor-derived cytokeratin monoclonal antibodies. J. Histochem. Cytochem., 37: 1845-1854, 1989.
38. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
39. 131I labeled human growth hormone with high specific radioactivity. J. Biochem. (Tokyo), 89: 114-123, 1963.
40. Murphy, R. M., Chamberlain, R. A., Schurtenberger, P., Colton, C. K., and Yarmush, M. L. Size and structure of antigen-antibody complexes: thermodynamic parameters. Biochemistry, 29: 10889-10899, 1990.
41. Schumaker, V. N., Seegan, G. W., Smith, C. A., Ma, S. K., Rodwell, J. D., and Schumaker, M. F. The free energy of angular position of the Fab arms of IgG antibody. Mol. Immunol., 17: 413-423, 1980.
42. Moyle, W. R., Lin, C., Corson, R. L., and Ehrlich, P. H. Quantitative explanation for increased affinity shown by mixtures of mAbs: importance of circular complex. Mol. Immunol., 20: 439-452, 1983.